FAMILY DIVISION
IN THE MATTER OF THE SENIOR COURTS ACT 1981
IN THE MATTER OF THE INHERENT JURISDICTION
AND IN THE MATTER OF X (A Child)
Strand, London, WC2A 2LL |
||
B e f o r e :
____________________
GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST |
Applicant |
|
and |
||
MX |
1st Respondent |
|
and |
||
FX |
2nd Respondent |
|
and |
||
X (A Child) (by her Cafcass guardian) |
3rd Respondent |
____________________
Debra Powell QC (instructed by Bindmans LLP) for the 1st and 2nd Respondents
Victoria Butler-Cole QC (instructed by Cafcass Legal) for the 3rd Respondent
Hearing dates: 30th June and 1st July 2020
____________________
Crown Copyright ©
Ms Justice Russell DBE:
Introduction
a) Endotracheal intubation,
b) invasive and non-invasive mechanical ventilation,
c) extracorporeal pulmonary support (ECMO),
d) inotropic support,
e) cardio-pulmonary resuscitation, except to the extent that a reversible cause can be identified for the cardiopulmonary arrest and cardio-pulmonary resuscitation is considered to be clinically appropriate,
f) renal replacement therapy,
g) elective surgery, except for emergency palliative surgery, and
h) re-admission to the paediatric intensive care unit for intensive care treatment, in the event that a discharge from the unit is achieved.
X's medical condition and history
Law
Applicant's case
1st and 2nd Respondents' position
The Child's case (by her guardian
i) Endotracheal intubation,
ii) Extracorporeal pulmonary support (ECMO),
iii) Inotropic support,
iv) Cardio-pulmonary resuscitation, save to the extent that a reversible cause can be identified for the cardiopulmonary arrest and cardio-pulmonary resuscitation is considered to be clinically appropriate,
v) Renal replacement therapy,
vi) Elective surgery except for emergency palliative surgery.
i) invasive and non-invasive mechanical ventilation (see below regarding Optiflow).
X's Best Interests
i) Four limb cerebral Palsy with dystonia. GMFCS level 5
ii) Cortical Blindness
iii) Hypoxic ischaemic cortical damage
iv) Basal Ganglia Stroke
v) Gastro-oesophageal reflux disease
vi) Haemolytic uraemic syndrome - led to renal failure treated with renal transplant
vii) Intestinal failure requiring hemicolectomy
viii) Previous Pancreatitis
ix) Laparoscopic Cholecystectomy March 2019
x) Subclavian vein thrombosis
xi) Lymphoedema due to venous insufficiency
xii) Intestinal failure, currently on full TPN, nil by gastrostomy.
Conclusions
i) There is a realistic prospect that Optiflow will ameliorate X's symptoms of respiratory distress and increased work of breathing,
ii) There is a realistic prospect that Optiflow will produce an improvement in X's respiratory function such that she will return to her pre-deterioration baseline.
i) If her condition improves such that she no longer requires ventilatory support,
ii) If, in the opinion of the senior clinician at the bedside, X shows signs of distress or discomfort as a consequence of receiving Optiflow,
iii) If X's respiratory function continues to deteriorate, despite treatment, such that she requires escalation of ventilatory support to either CPAP, BiPAP or invasive ventilation
iv) If X's respiratory function has not improved after treatment with Optiflow over a period of one week [7days].
i) As an alternative to CPAP, BiPAP or invasive mechanical ventilation,
ii) If, in the opinion of the senior clinician at the bedside, she has developed severe respiratory distress and/or she is actively dying,
iii) For more than two weeks [14 days].
Reporting restrictions order.
Note 1 http://www.ukcen.net/education_resources/support_guide/section_a_clinical_ethics_support [Back]